[O3–04–02]: DEVELOPING IN VIVO MODELS OF TAU PROPAGATION WHICH ARE RELEVANT TO HUMAN DISEASE PATHOGENESIS AND APPLICABLE TO PRE‐CLINICAL DRUG DISCOVERY. (1st July 2017)